18256 Federal Register / Vol. 80, No. 64 / Friday, April 3, 2015 / Notices 

in section 210.10 of the Commission’s Rules 

of Practice and Procedure, 19 CFR 210.10 

(2014). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

March 30, 2015, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain wireless standard 

compliant electronic devices, including 

communication devices and tablet 

computers, by reason of infringement of 

one or more of claims 1, 2, 4, 6, 7, 9, 

11–13, 15–19, 21, and 22 of the ’996 

patent; claims 7–12 and 18–23 of the 

’270 patent; claims 28–54 of the ’359 

patent; claims 1, 8–10, 12, 23, 24, 26, 27, 

29–31, 38–40, 42, 49, 50, 52, 53, 57, 58, 

64–66, and 68 of the ’556 patent; claims 

19, 20, 22–27, and 29–32 of the ’805 

patent; claims 1, 3, 5–8, 10, and 12–15 

of the ’130 patent; claims 1, 2, 4, 5, 7, 

11, and 13–15 of the ’381 patent; and 

claims 1, 3, 4, 6, 8, 9, 11, 12, 14, 16, 25, 

and 26 of the ’476 patent; and whether 

an industry in the United States exists 

as required by subsection (a)(2) of 

section 337; 

(2) Pursuant to Commission Rule 

210.50(b)(1), 19 CFR 210.50(b)(1), the 

presiding administrative law judge shall 

take evidence or other information and 

hear arguments from the parties and 

other interested persons with respect to 

the public interest in this investigation, 

as appropriate, and provide the 

Commission with findings of fact and a 

recommended determination on this 

issue, which shall be limited to the 

statutory public interest factors set forth 

in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1). 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainants are: Ericsson 

Inc., 6300 Legacy Drive, Plano, TX 

75024. 

Telefonaktiebolaget LM Ericsson, 

Torshamnsgatan 21, Kista, Stockholm, 

Sweden. 

(b) The respondent is the following 

entity alleged to be in violation of 

section 337, and is the party upon 

which the complaint is to be served: 

Apple Inc., a/k/a Apple Computer, Inc., 

1 Infinite Loop, Cupertino, CA 95014. 

(c) The Office of Unfair Import 

Investigations, U.S. International Trade 

Commission, 500 E Street SW., Suite 

401, Washington, DC 20436; and 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

A response to the complaint and the 

notice of investigation must be 

submitted by the named respondent in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), such a 

response will be considered by the 

Commission if received not later than 20 

days after the date of service by the 

Commission of the complaint and the 

notice of investigation. Extensions of 

time for submitting a response to the 

complaint and the notice of 

investigation will not be granted unless 

good cause therefor is shown. 

Failure of the respondent to file a 

timely response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: March 30, 2015. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2015–07647 Filed 4–2–15; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0024] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection; Reports of 

Regulated Transactions Involving 

Extraordinary Quantities, Uncommon 

Methods of Payment, and Unusual/

Excessive Loss or Disappearance, and 

Regulated Transactions in Tableting/

Encapsulating Machines 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration (DEA), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This proposed information collection 

was previously published in the Federal 

Register at 80 FR 6766, February 06, 

2015, allowing for a 60 day comment 

period. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until May 4, 2015. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other forms of 

information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Reports of Regulated Transactions 

Involving Extraordinary Quantities, 

Uncommon Methods of Payment, and 

Unusual/Excessive Loss or 

Disappearance, and Regulated 

Transactions in Tableting/Encapsulating 

Machines. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Notification of extraordinary quantities, 

uncommon methods of payment, and 

unusual/excessive loss or disappearance 

of listed chemicals and regulated 

transactions in tableting/encapsulating 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 64 / Friday, April 3, 2015 / Notices 18257 

machines is provided in writing on an 

as needed basis and does not require use 

of a form. The applicable component 

within the Department of Justice is the 

Drug Enforcement Administration, 

Office of Diversion Control. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Affected public (Primary): 

Business or other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, local, and 

tribal governments. 

Abstract: Each regulated person is 

required to report any regulated 

transaction involving an extraordinary 

quantity of a listed chemical, an 

uncommon method of payment or 

delivery, any unusual or excessive loss 

or disappearance of a listed chemical, 

and any regulated transaction in a 

tableting or encapsulating machine, to 

include any domestic regulated 

transaction in a tableting or 

encapsulating machine and any import 

or export of a tableting or encapsulating 

machine. 21 U.S.C. 830 (b)(1)(A), (C) 

and (D); 21 CFR 1310.05(a)(1), (3) and 

(4); 21 CFR 1310.05(c). 

Regulated persons include 

manufacturers, distributors, importers, 

and exporters of listed chemicals, 

tableting machines, or encapsulating 

machines, or persons who serve as 

brokers or traders for international 

transactions involving a listed chemical, 

tableting machine, or encapsulating 

machine. 21 CFR 1300.02(b). 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates that 63 

persons respond as needed to this 

collection. Responses take 20 minutes. 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: The DEA estimates 

that this collection takes 21 annual 

burden hours. 

If additional information is required 

please contact: Jerri Murray, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE., Suite 3E.405B, 

Washington, DC 20530. 

Jerri Murray, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2015–07666 Filed 4–2–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0012] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection Application for 

Registration, Application for 

Registration Renewal, Affidavit for 

Chain Renewal (DEA Forms 225, 225a 

and 225b) 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration (DEA), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This proposed information collection 

was previously published in the Federal 

Register at 80 FR, page 5137, on January 

30, 2015, allowing for a 60 day comment 

period. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until May 4, 2015. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is 

necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical 

utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions 

used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be 

collected can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use 

of appropriate automated, 

electronic, mechanical, or other 

forms of information technology, 

e.g., permitting electronic 

submission of responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Application for Registration, 

Application for Registration Renewal, 

Affidavit for Chain Renewal. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

The form numbers are DEA Forms 225, 

225a, and 225b. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Office of Diversion 

Control. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): Not-for-profit 

institutions, Federal, State, local, and 

tribal governments. 

Abstract: The Controlled Substances 

Act requires all businesses and 

individuals who manufacture, 

distribute, import, export, and conduct 

research and laboratory analysis with 

controlled substances to register with 

the DEA. 21 U.S.C. 822, 21 CFR 1301.11 

and 1301.13. Registration is a necessary 

control measure that prevents diversion 

by ensuring the closed system of 

distribution of controlled substances 

can be monitored by the DEA and that 

the businesses and individuals handling 

controlled substances are qualified to do 

so and are accountable. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: DEA Form 225 is only for 

registration of controlled substance 

manufacturers, distributors, reverse 

distributors, importers, exporters, 

researchers, canine handlers, and 

analytical laboratories, as well as list 1 

chemical manufacturers and importers. 

DEA Form 225 is submitted on an asneeded basis by persons seeking to 

become registered. DEA Form 225a is 

submitted annually thereafter to renew 

existing registrations. DEA Form 225b is 

submitted annually for renewals of 

chain registrants. Chain registrants are 

those corporations and laboratories that 

maintain separate registrations at 

multiple locations (e.g., distributors) 

and may renew all their registrations 

using a single DEA Form 225b. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES